Clinical trials
Phase 3 Dermatomyositis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Terminated | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Octapharma | 2 |
| Pfizer | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| CSL Behring | 1 |
| Corbus Pharmaceuticals Inc. | 1 |
| Institute of Rheumatology, Prague | 1 |
| Istituto Giannina Gaslini | 1 |
| Janssen Pharmaceutical K.K. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatomyositis | 16 |
| Polymyositis | 8 |
| Myositis | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.